Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during firs
- This topic has 0 replies, 1 voice, and was last updated 5 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT).
http://abstracts.asco.org/214/AbstView_214_228497.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.